Enhanced XPA mRNA levels in cisplatin-resistant human ovarian cancer are not associated with XPA mutations or gene amplification
- 29 November 1996
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 108 (2) , 233-237
- https://doi.org/10.1016/s0304-3835(96)04428-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- DNA repair and mutagenesisTrends in Genetics, 1996
- Characterization of the human XPA promoterGene, 1995
- Genomic copy number changes of DNA repair genes ERCC1 and ERCC2 in human gliomasJournal of Neuro-Oncology, 1995
- Cisplatin and DNA repair in cancer chemotherapyTrends in Biochemical Sciences, 1995
- Human DNA Repair Excision NucleaseJournal of Biological Chemistry, 1995
- The XPA protein is a zinc metalloprotein with an ability to recognize various kinds of DNA damageMutation Research/DNA Repair, 1994
- Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy.Journal of Clinical Investigation, 1994
- Cloning and characterization of the mouseXPACgeneNucleic Acids Research, 1994
- Genomic characterization of the human DNA excision repair-controlling geneXPACGene, 1993
- The rapid detection of unknown mutations in nucleic acidsNature Genetics, 1993